Company profile CLDX
After 92 days of this quarter the interest is at 316.0. Based on that we can calculate that during remaining 0 days it will total up to 316.0. Celldex Therapeutics expected interest is significantly higher compared to previous quarter (+110.7%) and same quarter last year (+206.8%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 174 |
| 2019 | 278 59.8% QoQ | 167 -39.9% QoQ | 150 -10.2% QoQ | 205 17.8% YoY 36.7% QoQ |
| 2020 | 39 -86.0% YoY -81.0% QoQ | 276 65.3% YoY 607.7% QoQ | 307 104.7% YoY 11.2% QoQ | 199 -2.9% YoY -35.2% QoQ |
| 2021 | 200 412.8% YoY 0.5% QoQ | 91 -67.0% YoY -54.5% QoQ | 166 -45.9% YoY 82.4% QoQ | 190 -4.5% YoY 14.5% QoQ |
| 2022 | 166 -17.0% YoY -12.6% QoQ | 104 14.3% YoY -37.3% QoQ | 103 -38.0% YoY -1.0% QoQ | 163 -14.2% YoY 58.3% QoQ |
| 2023 | 195 17.5% YoY 19.6% QoQ | 150 44.2% YoY -23.1% QoQ | 316 206.8% YoY 110.7% QoQ | 37 -77.3% YoY -88.3% QoQ |
The average 5 years interest of Celldex Therapeutics was 14.14 per week. The last year interest of Celldex Therapeutics compared to the last 5 years has changed by 17.11%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 11.97%.
There is not enough data for Celldex Therapeutics clinical trials to provide analysis
There is not enough data for Celldex Therapeutics clinical trials to provide correlation calculation
There is not enough data for Celldex Therapeutics clinical trials to provide analysis
There is not enough data for Celldex Therapeutics antibody therapies to provide analysis
There is not enough data for Celldex Therapeutics antibody therapies to provide correlation calculation
There is not enough data for Celldex Therapeutics antibody therapies to provide analysis
There is not enough data for Celldex Therapeutics cancer treatments to provide analysis
There is not enough data for Celldex Therapeutics cancer treatments to provide correlation calculation
There is not enough data for Celldex Therapeutics cancer treatments to provide analysis
There is not enough data for Celldex Therapeutics CDX-0159 to provide analysis
There is not enough data for Celldex Therapeutics CDX-0159 to provide correlation calculation
There is not enough data for Celldex Therapeutics CDX-0159 to provide analysis
There is not enough data for Celldex Therapeutics CDX-1140 to provide analysis
There is not enough data for Celldex Therapeutics CDX-1140 to provide correlation calculation
There is not enough data for Celldex Therapeutics CDX-1140 to provide analysis
There is not enough data for Celldex Therapeutics CDX-527 to provide analysis
There is not enough data for Celldex Therapeutics CDX-527 to provide correlation calculation
There is not enough data for Celldex Therapeutics CDX-527 to provide analysis
There is not enough data for Celldex Therapeutics stock price to provide analysis
There is not enough data for Celldex Therapeutics stock price to provide correlation calculation
There is not enough data for Celldex Therapeutics stock price to provide analysis
After 92 days of this quarter the interest is at 64.0. Based on that we can calculate that during remaining 0 days it will total up to 64.0. Celldex Therapeutics news expected interest is significantly higher compared to previous quarter (+137.0%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 246 |
| 2019 | 33 -86.6% QoQ | 100 203.0% QoQ | 99 -1.0% QoQ | 71 -71.1% YoY -28.3% QoQ |
| 2020 | 28 -15.2% YoY -60.6% QoQ | 97 -3.0% YoY 246.4% QoQ | 106 7.1% YoY 9.3% QoQ | 133 87.3% YoY 25.5% QoQ |
| 2021 | 161 475.0% YoY 21.1% QoQ | 0 -100.0% YoY -100.0% QoQ | 162 52.8% YoY inf% QoQ | 64 -51.9% YoY -60.5% QoQ |
| 2022 | 211 31.1% YoY 229.7% QoQ | 104 inf% YoY -50.7% QoQ | 64 -60.5% YoY -38.5% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 112 -46.9% YoY inf% QoQ | 27 -74.0% YoY -75.9% QoQ | 64 0.0% YoY 137.0% QoQ | 0 0.0% YoY -100.0% QoQ |
The average 5 years interest of Celldex Therapeutics news was 7.24 per week. The last year interest of Celldex Therapeutics news compared to the last 5 years has changed by -46.13%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -57.56%.
There is not enough data for Celldex Therapeutics -stock -company to provide analysis
There is not enough data for Celldex Therapeutics -stock -company to provide correlation calculation
There is not enough data for Celldex Therapeutics -stock -company to provide analysis